The Conversation (0)
RYAH Medtech Inc. (“RYAH” or the “Company”), announced today that its dose-measuring smart vaporizer and proprietary cartridges have hit medical dispensary shelves in the United States.
RYAH Medtech Inc. (“RYAH” or the “Company”), announced today that its dose-measuring smart vaporizer and proprietary cartridges have hit medical dispensary shelves in the United States. RYAH selected Sweetspot, a high-end medical dispensary located in Maryland for its flagship launch.
“We are excited to see RYAH on dispensary shelves in Maryland as a first step in our U.S. and international roll-out. Sweetspot’s compassionate ‘patient-first’ culture makes them a perfect partner for RYAH’s launch. Together, RYAH and Sweetspot aim to set a new precedent by delivering a state of the art plant-based dose-measuring regimen along with informative, customized patient consulting,” says Gregory Wagner, CEO of RYAH.
The RYAH vaporizer is a dose accuracy and control device that is able to precisely measure the amount of vapor a patient inhales. By capturing the complete plant strain lab results in conjunction with unprecedented temperature and dose control, RYAH creates a consistent and reliable vaporizing experience along with real-time, state-of-the-art data collection and analysis. The RYAH cloud solution provides doctors and patients with the ability to track which plant strains work best for their specific needs, while continuously collecting data for growers, dispensaries, pharmacies, laboratories and pharma companies to help improve the effectiveness of medical plant dosing. The data is integrated into RYAH’s big-data, AI platform, identifying correlations between plant strains and medical indications.
“We are excited to introduce this cutting edge device to our patients here in Maryland! Being able to teach patients about cannabinoid and terpene profiles in the store and then give them the ability to take this incredible device home to see what they learned in action is invaluable. This will give our patients the ability to really hone in on what specifically works for their bodies and will allow our staff to make better recommendations in the future,” says Peter Franklin, Dispensary Manager at Sweetspot.
“We are excited to see RYAH on dispensary shelves in Maryland as a first step in our U.S. and international roll-out. Sweetspot’s compassionate ‘patient-first’ culture makes them a perfect partner for RYAH’s launch. Together, RYAH and Sweetspot aim to set a new precedent by delivering a state of the art plant-based dose-measuring regimen along with informative, customized patient consulting,” says Gregory Wagner, CEO of RYAH.
About RYAH Medtech, Inc.
RYAH is a big data and technology company focused on valuable predictive analysis in the global medical plant intake industry. Its robust artificial intelligence platform aggregates and correlates HIPAA-compliant medical data, which is intended to help doctors and patients personalize plant-based treatments to better predict treatment outcomes. The data collection is also relevant for growers, dispensaries and Licensed Processors (LPs) to monitor and manage plant strain effects on patients. With a strong IP portfolio, RYAH gathers deep and insightful data on the complete medical plant lifecycle, from seed to consumption.
About Sweetspot
Sweetspot is a new medical cannabis dispensary in Olney, Maryland. Sweetspot caters to patients of all knowledge and experience with cannabis. We pride ourselves on educating our patients and making recommendations that can help with the patient’s medical condition.
Forward-Looking Statements
Certain statements contained in this press release constitute “forward-looking information” as such term is defined in applicable Canadian securities legislation and United States rules and regulation. The words “may”, “would”, “could”, “should”, “potential”, “will”, “seek”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” and similar expressions as they relate to the Company, execution of additional distribution agreements; and the results users may receive from using RYAH; are intended to identify forward-looking information. All statements other than statements of historical fact may be forward-looking information. Such statements reflect the Company’s current views and intentions with respect to future events, and current information available to the Company, and are subject to certain risks, uncertainties and assumptions. Many factors could cause the actual results, performance or achievements that may be expressed or implied by such forward-looking information to vary from those described herein should one or more of these risks or uncertainties materialize. These factors include, without limitation: the general business and economic conditions in the regions in which the Company operates; the ability of the Company to execute on key priorities, including the successful completion of acquisitions, business retention, and strategic plans and to attract, develop and retain key executives; difficulty integrating newly acquired businesses; the ability to implement business strategies and pursue business opportunities; disruptions in or attacks (including cyber-attacks) on the Company’s information technology, internet, network access or other voice or data communications systems or services; the evolution of various types of fraud or other criminal behavior to which the Company is exposed; the failure of third parties to comply with their obligations to the Company or its affiliates; the impact of new and changes to, or application of, current laws and regulations; a novel business model; granting of permits and licenses in a highly regulated business; the overall difficult litigation environment, including in the United States; increased competition; changes in foreign currency rates; increased funding costs and market volatility due to market illiquidity and competition for funding; the availability of funds and resources to pursue operations; critical accounting estimates and changes to accounting standards, policies, and methods used by the Company; the occurrence of natural and unnatural catastrophic events and claims resulting from such events; and the risk associated with a business in the cannabis industry. Should any factor affect the Company in an unexpected manner, or should assumptions underlying the forward-looking information prove incorrect, the actual results or events may differ materially from the results or events predicted. Any such forward-looking information is expressly qualified in its entirety by this cautionary statement. Moreover, the Company does not assume responsibility for the accuracy or completeness of such forward-looking information. The forward-looking information included in this press release is made as of the date of this press release and the Company undertakes no obligation to publicly update or revise any forward-looking information, other than as required by applicable law.
Click here to connect with RYAH Medtech Inc. for an Investor Presentation.
Source: www.globenewswire.com